Skip to main content

Atara Biotherapeutics misses IPO targets, dives, after raising $55M

Atara Biotherapeutics priced its IPO well below its target range, raising $55 million, and debuted on Wall Street at about 4 percent below where it sold its initial shares...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.